Discontinuation report MYLAN-PANTOPRAZOLE

Last updated on 2018-07-04 History
Report ID 51513
Drug Identification Number 02299585
Brand name MYLAN-PANTOPRAZOLE
Common or Proper name PANTOPRAZOLE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) PANTOPRAZOLE
Strength(s) 40MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging size 100 BT, 500 BT
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for discontinuation Business reasons
Anticipated discontinuation date 2018-07-03
Actual discontinuation date 2018-07-03
Remaining supply date 2018-07-03
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Discontinued in shortage ID 200. Last lot HL7667 Expires 30-Nov-19;
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2018-07-04 English Compare
v5 2018-07-03 French Compare
v4 2018-07-03 English Compare
v3 2018-06-05 French Compare
v2 2018-06-05 English Compare
v1 2018-06-05 English Compare

Showing 1 to 6 of 6